PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1983 April; 76(4): 245–249.
PMCID: PMC1438970

Prostacyclin.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (886K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Belch JJ, McKay A, McArdle B, Leiberman P, Pollock JG, Lowe GD, Forbes CD, Prentice CR. Epoprostenol (prostacyclin) and severe arterial disease. A double-blind trial. Lancet. 1983 Feb 12;1(8320):315–317. [PubMed]
  • Belch JJ, Newman P, Drury JK, Capell H, Leiberman P, James WB, Forbes CD, Prentice CR. Successful treatment of Raynaud's Syndrome with prostacyclin. Thromb Haemost. 1981 Jun 30;45(3):255–256. [PubMed]
  • Belch JJ, Newman P, Drury JK, McKenzie F, Capell H, Leiberman P, Forbes CD, Prentice CR. Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome. A double-blind controlled trial. Lancet. 1983 Feb 12;1(8320):313–315. [PubMed]
  • Bergman G, Daly K, Atkinson L, Rothman M, Richardson PJ, Jackson G, Jewitt DE. Prostacyclin: haemodynamic and metabolic effects in patients with coronary artery disease. Lancet. 1981 Mar 14;1(8220 Pt 1):569–572. [PubMed]
  • BERGSTROEM S, DANIELSSON H, SAMUELSSON B. THE ENZYMATIC FORMATION OF PROSTAGLANDIN E2 FROM ARACHIDONIC ACID PROSTAGLANDINS AND RELATED FACTORS 32. Biochim Biophys Acta. 1964 Jul 15;90:207–210. [PubMed]
  • Budd GT, Bukowski RM, Lucas FV, Cato AE, Cocchetto DM. Prostacyclin therapy of thrombotic thrombocytopenic purpura. Lancet. 1980 Oct 25;2(8200):915–915. [PubMed]
  • Chierchia S, Patrono C, Crea F, Ciabattoni G, De Caterina R, Cinotti GA, Distante A, Maseri A. Effects of intravenous prostacyclin in variant angina. Circulation. 1982 Mar;65(3):470–477. [PubMed]
  • Christ-Hazelhof E, Nugteren DH. Prostacyclin is not a circulating hormone. Prostaglandins. 1981 Nov;22(5):739–746. [PubMed]
  • Dembinska-Kiec A, Kostka-Trabka E, Gryglewski RJ. Effect of prostacyclin on fibrinolytic activity in patients with arteriosclerosis obliterans. Thromb Haemost. 1982 Apr 30;47(2):190–190. [PubMed]
  • VAN DORPD, BEERTHUIS RK, NUGTEREN DH, VONKEMAN H. THE BIOSYNTHESIS OF PROSTAGLANDINS. Biochim Biophys Acta. 1964 Jul 15;90:204–207. [PubMed]
  • Dowd PM, Martin MF, Cooke ED, Bowcock SA, Jones R, Dieppe PA, Kirby JD. Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2). Br J Dermatol. 1982 Jan;106(1):81–89. [PubMed]
  • Gimson AE, Braude S, Mellon PJ, Canalese J, Williams R. Earlier charcoal haemoperfusion in fulminant hepatic failure. Lancet. 1982 Sep 25;2(8300):681–683. [PubMed]
  • Gimson AE, Langley PG, Hughes RD, Canalese J, Mellon PJ, Williams R, Woods HF, Weston MJ. Prostacyclin to prevent platelet activation during charcoal haemoperfusion in fulminant hepatic failure. Lancet. 1980 Jan 26;1(8161):173–175. [PubMed]
  • Goehlert UG, Ng Ying Kin NM, Wolfe LS. Biosynthesis of prostacyclin in rat cerebral microvessels and the choroid plexus. J Neurochem. 1981 Mar;36(3):1192–1201. [PubMed]
  • Gorman RR, Hamilton RD, Hopkins NK. Stimulation of human foreskin fibroblast adenosine 3':5'-cyclic monophosphate levels by prostacyclin (prostaglandin I2). J Biol Chem. 1979 Mar 10;254(5):1671–1676. [PubMed]
  • Gryglewski RJ, Nowak S, Kostka-Trabka E, Bieroń K, Dembińska-Kieć A, Błaszczyk B, Kuśmiderski J, Markowska E, Szmatoła S. Clinical use of prostacyclin (PGI2) in ischaemic stroke. Pharmacol Res Commun. 1982 Oct;14(9):879–908. [PubMed]
  • Hall RJ, Dewar HA. Safety of coronary arterial prostacyclin infusion. Lancet. 1981 Apr 25;1(8226):949–949. [PubMed]
  • Hensby CN, Lewis PJ, Hilgard P, Mufti GJ, Hows J, Webster J. Prostacyclin deficiency in thrombotic thrombocytopenic purpura. Lancet. 1979 Oct 6;2(8145):748–748. [PubMed]
  • Hopkins NK, Gorman RR. Regulation of endothelial cell cyclic nucleotide metabolism by prostacyclin. J Clin Invest. 1981 Feb;67(2):540–546. [PMC free article] [PubMed]
  • Hory B, Saunier F, Roy C, Renevier A, Kieffer Y, Saint-Hillier Y, Perol C. Comparaison de la prostacycline et de l'heparinisation régionale au cours de la séance d'hémodialyse. Nouv Presse Med. 1982 Jul 10;11(32):2393–2397. [PubMed]
  • Kather H, Simon B. Effects of some naturally occurring prostaglandins of the D-, E-, and I-type and synthetic analogues on adenylate cyclase of human fat cell ghosts. Res Exp Med (Berl) 1979 Oct;176(1):25–29. [PubMed]
  • Leithner C, Sinzinger H, Schwarz M. Treatment of chronic kidney transplant rejection with prostacyclin - reduction of platelet deposition in the transplant; prolongation of platelet survival and improvement of transplant function. Prostaglandins. 1981 Nov;22(5):783–788. [PubMed]
  • Longmore DB, Bennett JG, Hoyle PM, Smith MA, Gregory A, Osivand T, Jones WA. Prostacyclin administration during cardiopulmonary bypass in man. Lancet. 1981 Apr 11;1(8224):800–804. [PubMed]
  • Moncada S. Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin. Br J Pharmacol. 1982 May;76(1):3–31. [PMC free article] [PubMed]
  • Moncada S, Vane JR. Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis. Br Med Bull. 1978 May;34(2):129–135. [PubMed]
  • Monden M, Fortner JG. Twenty-four- and 48-hour canine liver preservation by simple hypothermia with prostacyclin. Ann Surg. 1982 Jul;196(1):38–42. [PubMed]
  • Mundy AR, Bewick M, Moncada S, Vane JR. Short term suppression of hyperacute renal allograft rejection in presensitised dogs with prostacyclin. Prostaglandins. 1980 Apr;19(4):595–603. [PubMed]
  • Olsson AG. Intravenous prostacyclin for ischemic ulcers in peripheral artery disease. Lancet. 1980 Nov 15;2(8203):1076–1076. [PubMed]
  • Pardy BJ, Lewis JD, Eastcott HH. Preliminary experience with prostaglandins E1 and I2 in peripheral vascular disease. Surgery. 1980 Dec;88(6):826–832. [PubMed]
  • Peatfield RC, Gawel MJ, Rose FC. The effect of infused prostacyclin in migraine and cluster headache. Headache. 1981 Sep;21(5):190–195. [PubMed]
  • Piper PJ, Vane JR. Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs. Nature. 1969 Jul 5;223(5201):29–35. [PubMed]
  • Rådegran K, Egberg N, Papaconstantinou C. Effects of prostacyclin during cardiopulmonary bypass in man. Scand J Thorac Cardiovasc Surg. 1981;15(3):263–268. [PubMed]
  • Rubin LJ, Groves BM, Reeves JT, Frosolono M, Handel F, Cato AE. Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension. Circulation. 1982 Aug;66(2):334–338. [PubMed]
  • Samuelsson B, Borgeat P, Hammarström S, Murphy RC. Introduction of a nomenclature: leukotrienes. Prostaglandins. 1979 Jun;17(6):785–787. [PubMed]
  • Søreide O, Segadal L, Trippestad A, Engedal H. Salvage of the severely ischaemic limb by intra-arterial prostacyclin (PGI2) infusion. A case report. Scand J Thorac Cardiovasc Surg. 1982;16(1):71–73. [PubMed]
  • Starnes VA, Primm RK, Woosley RL, Oates JA, Hammon JW., Jr Administration of prostacyclin prevents ventricular fibrillation following coronary occlusion in conscious dogs. J Cardiovasc Pharmacol. 1982 Sep-Oct;4(5):765–769. [PubMed]
  • Szczeklik A, Nizankowski R, Skawinski S, Szczeklik J, Gluszko P, Gryglewski RJ. Successful therapy of advanced arteriosclerosis obliterans with prostacyclin. Lancet. 1979 May 26;1(8126):1111–1114. [PubMed]
  • Szczeklik J, Szczeklik A, Nizankowski R. Prostacyclin for pulmonary hypertension. Lancet. 1980 Nov 15;2(8203):1076–1076. [PubMed]
  • Tateson JE, Moncada S, Vane JR. Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets. Prostaglandins. 1977 Mar;13(3):389–397. [PubMed]
  • Turney JH, Dodd NJ, Weston MJ. Prostacyclin in extracorporeal circulations. Lancet. 1981 May 16;1(8229):1101–1101. [PubMed]
  • Turney JH, Weston MJ. Dialysis without anticoagulants. Lancet. 1981 Sep 26;2(8248):693–693. [PubMed]
  • Ubatuba FB, Moncada S, Vane JR. The effect of prostacyclin (PGT2) on platelet behaviour. Thrombus formation in vivo and bleeding time. Thromb Haemost. 1979 Apr 23;41(2):425–435. [PubMed]
  • Vane JR. Prostacyclin: a hormone with a therapeutic potential. The Sir Henry Dale Lecture for 1981. J Endocrinol. 1982 Nov;95(2):3P–43P. [PubMed]
  • Walker ID, Davidson JF, Faichney A, Wheatley DJ, Davidson KG. A double blind study of prostacyclin in cardiopulmonary bypass surgery. Br J Haematol. 1981 Nov;49(3):415–423. [PubMed]
  • Watkins WD, Peterson MB, Crone RK, Shannon DC, Levine L. Prostacyclin and prostaglandin E1 for severe idiopathic pulmonary artery hypertension. Lancet. 1980 May 17;1(8177):1083–1083. [PubMed]
  • Woods HF, Ash G, Weston MJ, Bunting S, Moncada S, Vane JR. Prostacyclin can replace heparin in haemodialysis in dogs. Lancet. 1978 Nov 18;2(8099):1075–1077. [PubMed]
  • Yui Y, Nakajima H, Kawai C, Murakami T. Prostacyclin therapy in patients with congestive heart failure. Am J Cardiol. 1982 Aug;50(2):320–324. [PubMed]
  • Zusman RM, Rubin RH, Cato AE, Cocchetto DM, Crow JW, Tolkoff-Rubin N. Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent. N Engl J Med. 1981 Apr 16;304(16):934–939. [PubMed]
  • Zygulska-Mach H, Kostka-Trabka E, Nitoń A, Gryglewski RJ. Prostacyclin in central retinal vein occlusion. Lancet. 1980 Nov 15;2(8203):1075–1075. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press